Loading...
NPI 1801495544 · Hammonton, NJ · Community/Retail Pharmacy
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Medilink Rxcare Hammonton, LLC is a community/retail pharmacy provider located in Hammonton, New Jersey. This profile covers 8 Medicare and 11 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Medilink Rxcare Hammonton, LLC |
| Address | 44 S White Horse Pike |
| City | Hammonton |
| State | NJ |
| ZIP | 08037 |
| Taxonomy | Community/Retail Pharmacy |
| NPI Enumerated | October 23, 2020 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $17.9M |
| Medicare | $23.8K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
8 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 70 | $140 | $9.7K |
| 90694 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is an inactivated, adjuvanted, preservative–free vaccine given as a 0.5 mL… | 70 | $70 | $5K |
| 91320 | This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 30 mcg/0.3 mL. | 20 | $130 | $2.8K |
| G0008 | Administration of influenza virus vaccine | 80 | $30 | $2.4K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 90 | $20 | $1.6K |
| 0134A | N/A | 30 | $40 | $1.5K |
| 0124A | N/A | 10 | $40 | $480 |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 10 | $20 | $230 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 8 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
11 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | 2,050 | $5,360 | $11M |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 1,690 | $1,830 | $3.1M |
| J0739 | Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | 580 | $3,490 | $2M |
| Q9991 | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg | 620 | $1,830 | $1.1M |
| J0578 | Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy | 190 | $1,680 | $322.2K |
| J2315 | Injection, naltrexone, depot form, 1 mg | 220 | $1,260 | $274K |
| J3490 | Unclassified drugs | 90 | $480 | $44.8K |
| M0201 | Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patient's home; reported only once per individual home per date of service when such vaccine administration(s)… | 20 | $1 | $80 |
| 0001A | N/A | 20 | $0 | $0 |
| 0011A | N/A | 20 | $0 | $0 |
Showing 1–10 of 11
How this provider's Medicaid billing volume and revenue compare to other New Jersey providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New Jersey median
11 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | 1 | 10 | 230 | $4,480 | $2.9M |
| J0739 | Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | 1 | 10 | 580 | $3,490 | $2M |
| J2315 | Injection, naltrexone, depot form, 1 mg | 3 | 10 | 320 | $1,140 | $1.7M |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 3 | 10 | 880 | $1,250 | $1.6M |
| Q9991 | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg | 2 | 10 | 430 | $1,690 | $917.9K |
| J0578 | Injection, buprenorphine extended release (brixadi), greater than 7 days and up to 28 days of therapy | 1 | 10 | 40 | $1,450 | $88.4K |
| J3490 | Unclassified drugs | 76 | 100 | 880 | $1 | $30.5K |
| 0001A | N/A | 164 | 210 | 70 | $30 | $12K |
| 0012A | N/A | 135 | 170 | 80 | $30 | $6.9K |
| 0011A | N/A | 141 | 180 | 70 | $20 | $5.5K |
Showing 1–10 of 11
Other providers in the same ZIP code as Medilink Rxcare Hammonton, LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Onward Behavioral Health | NJ | Substance Abuse Rehabilitation Facility | $0 | $61.1M |
| Allied Behavioral Healthcare Services | NJ | Community/Behavioral Health Agency | $0 | $43.9M |
| Atlanticare Behvioral Health, Inc. | NJ | Community/Behavioral Health Agency | $0 | $14M |
| Asapp Healthcare Inc | NJ | Community/Behavioral Health Agency | $0 | $11.1M |
| Rt. 206 Inc. | NJ | Assisted Living Facility | $0 | $8.8M |
| Young J. Lee | NJ | Interventional Pain Medicine Physician | $479.3K | $0 |
| Amy Chojnacki | NJ | Adult Health Nurse Practitioner | $373.3K | $0 |
| Matthew Crescenzo | NJ | Physical Therapist | $315.6K | $0 |
| Amerigo Falciani | NJ | Diagnostic Radiology Physician | $303.8K | $0 |
| Albert Belli | NJ | Pulmonary Disease Physician | $295.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.